8-K: Perrigo Reports Record Net Sales and Launches 'Project Energize' Investment Program

Perrigo announced record net sales for both the fourth quarter and fiscal year 2023, alongside the launch of a new investment and efficiency program called 'Project Energize'.

Summary

• Perrigo reported record net sales from continuing operations for both the fourth quarter and fiscal year 2023.
• Fourth quarter net sales reached $1.2 billion, a 0.1% increase year-over-year, while organic net sales decreased by 0.6%.
• Fiscal year 2023 net sales totaled $4.7 billion, a 4.6% increase compared to the previous year, with organic net sales up by 1.7%.
• The company's gross margin improved significantly, with a 380 basis points increase in the fourth quarter and a 340 basis points increase for the full year.
• Adjusted diluted earnings per share (EPS) for the fourth quarter was $0.86, a 14.7% increase, and $2.58 for the full year, a 24.6% increase.
• Perrigo is launching 'Project Energize', a three-year investment and efficiency program expected to deliver $140 million to $170 million in annualized pre-tax savings by 2026.
• The company anticipates reinvesting $40 million to $60 million of these savings to drive its blended-branded business model.
• Restructuring charges related to Project Energize are estimated to be between $140 million and $160 million, with a net reduction of approximately 6% of total Perrigo roles.
• The company's fiscal year 2024 outlook includes organic net sales growth of 1.0% to 3.0% and flat reported net sales compared to the prior year.
• Adjusted diluted EPS for 2024 is projected to be in the range of $2.50 to $2.65, representing mid-teens growth excluding the impact of infant formula.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with strong financial results and a strategic plan for future growth. However, the headwinds in the infant formula business and the restructuring program temper the overall sentiment.

Positives

• Perrigo achieved record net sales for both the fourth quarter and fiscal year 2023.
• The company experienced significant improvements in gross margin for both the fourth quarter and the full year.
• Adjusted diluted EPS showed strong growth for both the fourth quarter and the full year.
• The launch of 'Project Energize' is expected to drive significant cost savings and improve long-term business performance.
• The company's international business is performing strongly.
• Perrigo's accretive initiatives are on track, contributing to positive financial results.
• Operating cash flow conversion for fiscal year 2023 was 115%.

Negatives

• Organic net sales decreased by 0.6% in the fourth quarter, impacted by SKU prioritization and distributor transitions.
• The company reported a GAAP loss per share of $(0.20) in the fourth quarter.
• The company's infant formula business is facing headwinds, which will negatively impact 2024 financial performance.
• Restructuring activities as part of 'Project Energize' will result in a net reduction of approximately 6% of total Perrigo roles.
• The company expects to incur $140 million to $160 million in restructuring charges related to 'Project Energize'.

Risks

• The company's infant formula business is facing headwinds, which will negatively impact 2024 financial performance.
• Restructuring activities as part of 'Project Energize' will result in a net reduction of approximately 6% of total Perrigo roles.
• The company expects to incur $140 million to $160 million in restructuring charges related to 'Project Energize'.
• The company's 2024 outlook is subject to uncertainties, including non-recurring infant formula related charges and timing of restructuring charges.
• The company's future performance is subject to various risks, including supply chain impacts, economic conditions, competition, and regulatory changes.

Future Outlook

The company's fiscal year 2024 outlook includes organic net sales growth of 1.0% to 3.0% and flat reported net sales compared to the prior year. Adjusted diluted EPS for 2024 is projected to be in the range of $2.50 to $2.65, representing mid-teens growth excluding the impact of infant formula.

Management Comments

• Patrick Lockwood-Taylor, President and CEO, stated that Perrigo made meaningful progress on its blueprint to build One Perrigo in 2023.
• Lockwood-Taylor mentioned that the company is working towards establishing sustainable, value accretive growth through a blended-branded business model.
• He also noted that 'Project Energize' is designed to consumerize, simplify, and scale the organization.
• Lockwood-Taylor stated that the company exited 2023 with its international business performing strongly and its U.S. OTC business performing well.
• He acknowledged that actions to augment and strengthen the infant formula business will negatively impact 2024 financial performance but expressed confidence in the long-term benefits.

Industry Context

This announcement reflects Perrigo's ongoing efforts to streamline operations and focus on its core consumer self-care business. The launch of 'Project Energize' aligns with industry trends of companies seeking efficiency and cost savings. The company's focus on a blended-branded business model is a common strategy in the consumer healthcare sector.

Comparison to Industry Standards

• Perrigo's adjusted gross margin of 39.8% for Q4 2023 is comparable to other major consumer healthcare companies such as Haleon (which reported an adjusted operating margin of 23.2% for the full year 2023) and Reckitt Benckiser (which reported an adjusted operating margin of 22.9% for the full year 2023).
• The company's focus on organic growth and cost savings through 'Project Energize' is similar to initiatives undertaken by competitors to improve profitability and shareholder value.
• Perrigo's adjusted diluted EPS growth of 24.6% for fiscal year 2023 is strong compared to the industry average, but the 2024 outlook is more conservative due to the infant formula headwinds.
• The restructuring program is similar to those undertaken by other large consumer goods companies to improve efficiency and reduce costs, such as Unilever's recent restructuring program.

Stakeholder Impact

• Shareholders will benefit from improved financial performance and the potential for long-term growth.
• Employees may be impacted by the restructuring program, which will result in a net reduction of approximately 6% of total roles.
• Customers will benefit from the company's focus on a blended-branded business model and improved product offerings.
• Suppliers may be impacted by changes in the company's supply chain as part of the 'Project Energize' program.
• Creditors will be impacted by the company's financial performance and debt management.

Next Steps

• Perrigo will initiate 'Project Energize' in Q1 2024.
• The company will provide additional details about 'Project Energize' on the earnings webcast and conference call.
• Perrigo will continue to execute its blended-branded business model strategy.
• The company will focus on stabilizing and strengthening its infant formula business in 2024.

Key Dates

Keywords

Perrigo, Consumer Self-Care, Project Energize, Net Sales, Gross Margin, EPS, Restructuring, Organic Growth, Infant Formula, Operating Income